0

Close
 
Upcoming Allied Market Research
2023
Marine Biotechnology Market

Marine Biotechnology Market

by Product Type (Marine Animal Technology, Marine Plant Technology, Marine Biotechnology), by Application (Cosmetics, Pharmaceuticals, Fine Chemical, Nutritional Supplements) and by End Use Industries (Pharmaceutical, Biotechnological): Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Diagnostics and Biotech
Report Code: A12481
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Marine Biotechnology Market

Request Now !

Marine Biotechnology Market Overview 2030:

Marine biotechnology is a growing field that comprises marine bio-medicines, including pharmaceuticals discovery, materials technology, bio remediation, marine biomedical model organism, genomics, bioinformatics, and molecular genetics. The prime motivation for this discipline is clearly derived from the enormous biodiversity and genetic life in sea. The marine environment is a rich source of both chemical and biological diversity. This diversity consists of compounds with the potential for industrial development such as in cosmetics, nutritional supplements, pharmaceuticals, molecular probes, enzymes, fine chemicals, and agrichemicals.

It comprises a broad range of categories such as marine environmental protection, genetics, marine bioactive substances, marine biomaterials, marine culture, fermentation engineering, and enzyme engineering. Although marine biotechnology market is in a nascent stage, it has untapped potential and promising growth prospect for future. The fundamental end user applications of marine products are industrial products, healthcare/biotechnology, consumer products, public services, and infrastructure. This technology lends maximum utilization of marine resources and also conserves and safeguards these resources. Marine biotechnological advancements have already resulted in some successes in diverse fields, including human health, pharmacology, fisheries, environmental recovery or restoration, food & cosmetics industries, agriculture, and chemistry.

COVID-19 Impact Analysis

  • COVID-19 is an infectious disease that originated in the Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since its outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
  • Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs have presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected to witness a significant growth in the future, owing to the demand for vaccine and treatment drugs for COVID-19. This, in turn, is expected to have a significant impact on the marine biotechnology market.
  • The recession caused by the pandemic has now cast serious questions on the ability of governments and companies to earmark financial commitments in times of crisis. The only hope for the market in successfully mitigating the short and long-term damage of the crisis, is securing fiscal stimulus from governments. Most R&D budgets which are so vital for innovation are largely dependent upon financial support from governments. Healthy financial performance of companies also determines the extent of willingness to reinvest earnings into R&D and new product development. Biopharmaceutical companies are witnessing their market cap rise significantly.
  • While the global economy slows down, pharma biotechnology firms both big and small is expected to fearlessly continue to innovate and bring hope.

Top Impacting Factors

  • Growth in usage of marine products in food, cosmetics, and agriculture industries drives the market for marine biotechnology. In addition, advances in drug discovery, fisheries, and aquaculture are the factors that drive the market. Lack of R&D investment in biotechnology is constraining the growth of the market. Lack of exploration in oceans is constraining the growth as many untold marine resources (animals and plants) are extinct even before their proper useful characteristics are discovered.
  • Energy supply on a global scale is increasingly needed and marine biotechnology can make an important contribution to meeting these energy needs in very different ways. Microbial Enhanced Oil Recovery (MEOR), for example, a bio-based approach to enhancing the recovery efficiency of fossil oil reserves, could help to increase the life of mature oil reservoirs. Cultivating microalgae for bio-energy generation is a big challenge and one of marine biotechnology’s key objectives. Thus, owing to these factors, the market of marine biotechnology is anticipated to rise during the forecast period.
  • Expensive discovery process and regulations from government act as a restraint to the market. Other than that, many barriers exist in the market such as the technical barriers, related to the expensive discovery process, limited capacity to develop organisms in the laboratory and on large-scale financial barriers, due to the relatively low profile of marine biotechnology resulting in underfunding, and legal and regulatory barriers, particularly regarding access to marine resources. A limiting factor for the sector could well be the increased need for large infrastructure investments. Hence, owing to such barriers, the marine biotechnology market is anticipated to face hurdles during the forecast period.

Market Trends

Europe dominated the marine biotechnology market due to technological advancements in marine biotechnology, growth in demand from the cosmetic industry, and increase in demand for the development of biofuels.

Marine biotechnology represents one of the youngest approaches to biotechnology. Rich biodiversity exists in the marine world and the organisms themselves include essential biochemical compounds with a broad variety of uses in medicine, climate, and other industries.

New applications of marine-derived enzymes in the cosmetics industry, the use of marine algae & microalgae for biofuel production, and the production of marine-derived polysaccharides, which are among the most abundant renewable biomaterials found on land and in the oceans, are the key drivers that are anticipated to boost the market growth.

Key Benefits of the Report

  • This report presents the detailed study of the marine biotechnology market along with its current trends and future investment scope.
  • This study has complete information regarding key drivers, restraints, new technological development in the marine biotechnology market.
  • The market is analyzed to highlight the growth of the marine biotechnology market.
  • Porter’s five forces analysis illustrates the potency of buyers and suppliers in the market.
  • The report provides a detailed marine biotechnology market analysis based on competition between key players and how it will shape in upcoming years.

Questions Answered in the Marine Biotechnology Market Report

  • What consists of marine biotechnology market?
  • What are the current trends in the marine biotechnology market?
  • What are the driving factors, restraints and, opportunities of the market?
  • Who are the major end user sectors in marine biotechnology market?
  • What is the major regional market in marine biotechnology market?
  • What are the future projections that will help in making strategic steps?
  • What are the key benefits of this marine biotechnology report?

 Marine Biotechnology Market Report Highlights

Aspects Details
By Product Type
  • Marine Animal Technology
  • Marine Plant Technology
  • Marine Biotechnology
By Application
  • Cosmetics
  • Pharmaceuticals
  • Fine Chemical
  • Nutritional Supplements
By End Use Industries
  • Pharmaceutical
  • Biotechnological
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Cyanotech Corp., Aker BioMarine AS, Lonza Group Ltd., NovaMatrix, Nutrex Hawaii Inc., BASF SE, Marinova Pty Ltd, New England Biolabs Inc, CP Kelco, GlycoMar Ltd.
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: MARINE BIOTECHNOLOGY MARKET, BY PRODUCT TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product Type

    • 4.2. Marine Animal Technology

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Marine Plant Technology

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Marine Biotechnology

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

  • CHAPTER 5: MARINE BIOTECHNOLOGY MARKET, BY APPLICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Application

    • 5.2. Cosmetics

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Pharmaceuticals

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Fine Chemical

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Nutritional Supplements

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

  • CHAPTER 6: MARINE BIOTECHNOLOGY MARKET, BY END USE INDUSTRIES

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By End Use Industries

    • 6.2. Pharmaceutical

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Biotechnological

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

  • CHAPTER 7: MARINE BIOTECHNOLOGY MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Product Type

      • 7.2.3. Market Size and Forecast, By Application

      • 7.2.4. Market Size and Forecast, By End Use Industries

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Marine Biotechnology Market

        • 7.2.6.1. Market Size and Forecast, By Product Type
        • 7.2.6.2. Market Size and Forecast, By Application
        • 7.2.6.3. Market Size and Forecast, By End Use Industries

      • 7.2.7. Canada Marine Biotechnology Market

        • 7.2.7.1. Market Size and Forecast, By Product Type
        • 7.2.7.2. Market Size and Forecast, By Application
        • 7.2.7.3. Market Size and Forecast, By End Use Industries

      • 7.2.8. Mexico Marine Biotechnology Market

        • 7.2.8.1. Market Size and Forecast, By Product Type
        • 7.2.8.2. Market Size and Forecast, By Application
        • 7.2.8.3. Market Size and Forecast, By End Use Industries

    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Product Type

      • 7.3.3. Market Size and Forecast, By Application

      • 7.3.4. Market Size and Forecast, By End Use Industries

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Marine Biotechnology Market

        • 7.3.6.1. Market Size and Forecast, By Product Type
        • 7.3.6.2. Market Size and Forecast, By Application
        • 7.3.6.3. Market Size and Forecast, By End Use Industries

      • 7.3.7. Germany Marine Biotechnology Market

        • 7.3.7.1. Market Size and Forecast, By Product Type
        • 7.3.7.2. Market Size and Forecast, By Application
        • 7.3.7.3. Market Size and Forecast, By End Use Industries

      • 7.3.8. Italy Marine Biotechnology Market

        • 7.3.8.1. Market Size and Forecast, By Product Type
        • 7.3.8.2. Market Size and Forecast, By Application
        • 7.3.8.3. Market Size and Forecast, By End Use Industries

      • 7.3.9. Spain Marine Biotechnology Market

        • 7.3.9.1. Market Size and Forecast, By Product Type
        • 7.3.9.2. Market Size and Forecast, By Application
        • 7.3.9.3. Market Size and Forecast, By End Use Industries

      • 7.3.10. UK Marine Biotechnology Market

        • 7.3.10.1. Market Size and Forecast, By Product Type
        • 7.3.10.2. Market Size and Forecast, By Application
        • 7.3.10.3. Market Size and Forecast, By End Use Industries

      • 7.3.11. Russia Marine Biotechnology Market

        • 7.3.11.1. Market Size and Forecast, By Product Type
        • 7.3.11.2. Market Size and Forecast, By Application
        • 7.3.11.3. Market Size and Forecast, By End Use Industries

      • 7.3.12. Rest Of Europe Marine Biotechnology Market

        • 7.3.12.1. Market Size and Forecast, By Product Type
        • 7.3.12.2. Market Size and Forecast, By Application
        • 7.3.12.3. Market Size and Forecast, By End Use Industries

    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Product Type

      • 7.4.3. Market Size and Forecast, By Application

      • 7.4.4. Market Size and Forecast, By End Use Industries

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Marine Biotechnology Market

        • 7.4.6.1. Market Size and Forecast, By Product Type
        • 7.4.6.2. Market Size and Forecast, By Application
        • 7.4.6.3. Market Size and Forecast, By End Use Industries

      • 7.4.7. Japan Marine Biotechnology Market

        • 7.4.7.1. Market Size and Forecast, By Product Type
        • 7.4.7.2. Market Size and Forecast, By Application
        • 7.4.7.3. Market Size and Forecast, By End Use Industries

      • 7.4.8. India Marine Biotechnology Market

        • 7.4.8.1. Market Size and Forecast, By Product Type
        • 7.4.8.2. Market Size and Forecast, By Application
        • 7.4.8.3. Market Size and Forecast, By End Use Industries

      • 7.4.9. South Korea Marine Biotechnology Market

        • 7.4.9.1. Market Size and Forecast, By Product Type
        • 7.4.9.2. Market Size and Forecast, By Application
        • 7.4.9.3. Market Size and Forecast, By End Use Industries

      • 7.4.10. Australia Marine Biotechnology Market

        • 7.4.10.1. Market Size and Forecast, By Product Type
        • 7.4.10.2. Market Size and Forecast, By Application
        • 7.4.10.3. Market Size and Forecast, By End Use Industries

      • 7.4.11. Thailand Marine Biotechnology Market

        • 7.4.11.1. Market Size and Forecast, By Product Type
        • 7.4.11.2. Market Size and Forecast, By Application
        • 7.4.11.3. Market Size and Forecast, By End Use Industries

      • 7.4.12. Malaysia Marine Biotechnology Market

        • 7.4.12.1. Market Size and Forecast, By Product Type
        • 7.4.12.2. Market Size and Forecast, By Application
        • 7.4.12.3. Market Size and Forecast, By End Use Industries

      • 7.4.13. Indonesia Marine Biotechnology Market

        • 7.4.13.1. Market Size and Forecast, By Product Type
        • 7.4.13.2. Market Size and Forecast, By Application
        • 7.4.13.3. Market Size and Forecast, By End Use Industries

      • 7.4.14. Rest of Asia Pacific Marine Biotechnology Market

        • 7.4.14.1. Market Size and Forecast, By Product Type
        • 7.4.14.2. Market Size and Forecast, By Application
        • 7.4.14.3. Market Size and Forecast, By End Use Industries

    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Product Type

      • 7.5.3. Market Size and Forecast, By Application

      • 7.5.4. Market Size and Forecast, By End Use Industries

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Marine Biotechnology Market

        • 7.5.6.1. Market Size and Forecast, By Product Type
        • 7.5.6.2. Market Size and Forecast, By Application
        • 7.5.6.3. Market Size and Forecast, By End Use Industries

      • 7.5.7. South Africa Marine Biotechnology Market

        • 7.5.7.1. Market Size and Forecast, By Product Type
        • 7.5.7.2. Market Size and Forecast, By Application
        • 7.5.7.3. Market Size and Forecast, By End Use Industries

      • 7.5.8. Saudi Arabia Marine Biotechnology Market

        • 7.5.8.1. Market Size and Forecast, By Product Type
        • 7.5.8.2. Market Size and Forecast, By Application
        • 7.5.8.3. Market Size and Forecast, By End Use Industries

      • 7.5.9. UAE Marine Biotechnology Market

        • 7.5.9.1. Market Size and Forecast, By Product Type
        • 7.5.9.2. Market Size and Forecast, By Application
        • 7.5.9.3. Market Size and Forecast, By End Use Industries

      • 7.5.10. Argentina Marine Biotechnology Market

        • 7.5.10.1. Market Size and Forecast, By Product Type
        • 7.5.10.2. Market Size and Forecast, By Application
        • 7.5.10.3. Market Size and Forecast, By End Use Industries

      • 7.5.11. Rest of LAMEA Marine Biotechnology Market

        • 7.5.11.1. Market Size and Forecast, By Product Type
        • 7.5.11.2. Market Size and Forecast, By Application
        • 7.5.11.3. Market Size and Forecast, By End Use Industries

  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning,2022

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Aker BioMarine AS

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. BASF SE

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. CP Kelco

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. Cyanotech Corp.

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. GlycoMar Ltd.

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. Lonza Group Ltd.

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Marinova Pty Ltd

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. New England Biolabs Inc

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. NovaMatrix

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. Nutrex Hawaii Inc.

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL MARINE BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL MARINE BIOTECHNOLOGY MARKET FOR MARINE ANIMAL TECHNOLOGY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL MARINE BIOTECHNOLOGY MARKET FOR MARINE PLANT TECHNOLOGY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL MARINE BIOTECHNOLOGY MARKET FOR MARINE BIOTECHNOLOGY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL MARINE BIOTECHNOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL MARINE BIOTECHNOLOGY MARKET FOR COSMETICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL MARINE BIOTECHNOLOGY MARKET FOR PHARMACEUTICALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL MARINE BIOTECHNOLOGY MARKET FOR FINE CHEMICAL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL MARINE BIOTECHNOLOGY MARKET FOR NUTRITIONAL SUPPLEMENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL MARINE BIOTECHNOLOGY MARKET, BY END USE INDUSTRIES, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL MARINE BIOTECHNOLOGY MARKET FOR PHARMACEUTICAL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL MARINE BIOTECHNOLOGY MARKET FOR BIOTECHNOLOGICAL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL MARINE BIOTECHNOLOGY MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. NORTH AMERICA MARINE BIOTECHNOLOGY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. NORTH AMERICA MARINE BIOTECHNOLOGY, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 16. NORTH AMERICA MARINE BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 17. NORTH AMERICA MARINE BIOTECHNOLOGY, BY END USE INDUSTRIES, 2022-2032 ($MILLION)
  • TABLE 18. U.S. MARINE BIOTECHNOLOGY, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 19. U.S. MARINE BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 20. U.S. MARINE BIOTECHNOLOGY, BY END USE INDUSTRIES, 2022-2032 ($MILLION)
  • TABLE 21. CANADA MARINE BIOTECHNOLOGY, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 22. CANADA MARINE BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 23. CANADA MARINE BIOTECHNOLOGY, BY END USE INDUSTRIES, 2022-2032 ($MILLION)
  • TABLE 24. MEXICO MARINE BIOTECHNOLOGY, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 25. MEXICO MARINE BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 26. MEXICO MARINE BIOTECHNOLOGY, BY END USE INDUSTRIES, 2022-2032 ($MILLION)
  • TABLE 27. EUROPE MARINE BIOTECHNOLOGY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 28. EUROPE MARINE BIOTECHNOLOGY, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 29. EUROPE MARINE BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 30. EUROPE MARINE BIOTECHNOLOGY, BY END USE INDUSTRIES, 2022-2032 ($MILLION)
  • TABLE 31. FRANCE MARINE BIOTECHNOLOGY, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 32. FRANCE MARINE BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 33. FRANCE MARINE BIOTECHNOLOGY, BY END USE INDUSTRIES, 2022-2032 ($MILLION)
  • TABLE 34. GERMANY MARINE BIOTECHNOLOGY, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 35. GERMANY MARINE BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 36. GERMANY MARINE BIOTECHNOLOGY, BY END USE INDUSTRIES, 2022-2032 ($MILLION)
  • TABLE 37. ITALY MARINE BIOTECHNOLOGY, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 38. ITALY MARINE BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 39. ITALY MARINE BIOTECHNOLOGY, BY END USE INDUSTRIES, 2022-2032 ($MILLION)
  • TABLE 40. SPAIN MARINE BIOTECHNOLOGY, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 41. SPAIN MARINE BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 42. SPAIN MARINE BIOTECHNOLOGY, BY END USE INDUSTRIES, 2022-2032 ($MILLION)
  • TABLE 43. UK MARINE BIOTECHNOLOGY, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 44. UK MARINE BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 45. UK MARINE BIOTECHNOLOGY, BY END USE INDUSTRIES, 2022-2032 ($MILLION)
  • TABLE 46. RUSSIA MARINE BIOTECHNOLOGY, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 47. RUSSIA MARINE BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 48. RUSSIA MARINE BIOTECHNOLOGY, BY END USE INDUSTRIES, 2022-2032 ($MILLION)
  • TABLE 49. REST OF EUROPE MARINE BIOTECHNOLOGY, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 50. REST OF EUROPE MARINE BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 51. REST OF EUROPE MARINE BIOTECHNOLOGY, BY END USE INDUSTRIES, 2022-2032 ($MILLION)
  • TABLE 52. ASIA-PACIFIC MARINE BIOTECHNOLOGY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 53. ASIA-PACIFIC MARINE BIOTECHNOLOGY, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 54. ASIA-PACIFIC MARINE BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 55. ASIA-PACIFIC MARINE BIOTECHNOLOGY, BY END USE INDUSTRIES, 2022-2032 ($MILLION)
  • TABLE 56. CHINA MARINE BIOTECHNOLOGY, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 57. CHINA MARINE BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 58. CHINA MARINE BIOTECHNOLOGY, BY END USE INDUSTRIES, 2022-2032 ($MILLION)
  • TABLE 59. JAPAN MARINE BIOTECHNOLOGY, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 60. JAPAN MARINE BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 61. JAPAN MARINE BIOTECHNOLOGY, BY END USE INDUSTRIES, 2022-2032 ($MILLION)
  • TABLE 62. INDIA MARINE BIOTECHNOLOGY, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 63. INDIA MARINE BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 64. INDIA MARINE BIOTECHNOLOGY, BY END USE INDUSTRIES, 2022-2032 ($MILLION)
  • TABLE 65. SOUTH KOREA MARINE BIOTECHNOLOGY, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 66. SOUTH KOREA MARINE BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 67. SOUTH KOREA MARINE BIOTECHNOLOGY, BY END USE INDUSTRIES, 2022-2032 ($MILLION)
  • TABLE 68. AUSTRALIA MARINE BIOTECHNOLOGY, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 69. AUSTRALIA MARINE BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 70. AUSTRALIA MARINE BIOTECHNOLOGY, BY END USE INDUSTRIES, 2022-2032 ($MILLION)
  • TABLE 71. THAILAND MARINE BIOTECHNOLOGY, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 72. THAILAND MARINE BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 73. THAILAND MARINE BIOTECHNOLOGY, BY END USE INDUSTRIES, 2022-2032 ($MILLION)
  • TABLE 74. MALAYSIA MARINE BIOTECHNOLOGY, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 75. MALAYSIA MARINE BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 76. MALAYSIA MARINE BIOTECHNOLOGY, BY END USE INDUSTRIES, 2022-2032 ($MILLION)
  • TABLE 77. INDONESIA MARINE BIOTECHNOLOGY, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 78. INDONESIA MARINE BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 79. INDONESIA MARINE BIOTECHNOLOGY, BY END USE INDUSTRIES, 2022-2032 ($MILLION)
  • TABLE 80. REST OF ASIA PACIFIC MARINE BIOTECHNOLOGY, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 81. REST OF ASIA PACIFIC MARINE BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 82. REST OF ASIA PACIFIC MARINE BIOTECHNOLOGY, BY END USE INDUSTRIES, 2022-2032 ($MILLION)
  • TABLE 83. LAMEA MARINE BIOTECHNOLOGY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 84. LAMEA MARINE BIOTECHNOLOGY, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 85. LAMEA MARINE BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 86. LAMEA MARINE BIOTECHNOLOGY, BY END USE INDUSTRIES, 2022-2032 ($MILLION)
  • TABLE 87. BRAZIL MARINE BIOTECHNOLOGY, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 88. BRAZIL MARINE BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 89. BRAZIL MARINE BIOTECHNOLOGY, BY END USE INDUSTRIES, 2022-2032 ($MILLION)
  • TABLE 90. SOUTH AFRICA MARINE BIOTECHNOLOGY, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 91. SOUTH AFRICA MARINE BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 92. SOUTH AFRICA MARINE BIOTECHNOLOGY, BY END USE INDUSTRIES, 2022-2032 ($MILLION)
  • TABLE 93. SAUDI ARABIA MARINE BIOTECHNOLOGY, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 94. SAUDI ARABIA MARINE BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 95. SAUDI ARABIA MARINE BIOTECHNOLOGY, BY END USE INDUSTRIES, 2022-2032 ($MILLION)
  • TABLE 96. UAE MARINE BIOTECHNOLOGY, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 97. UAE MARINE BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 98. UAE MARINE BIOTECHNOLOGY, BY END USE INDUSTRIES, 2022-2032 ($MILLION)
  • TABLE 99. ARGENTINA MARINE BIOTECHNOLOGY, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 100. ARGENTINA MARINE BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 101. ARGENTINA MARINE BIOTECHNOLOGY, BY END USE INDUSTRIES, 2022-2032 ($MILLION)
  • TABLE 102. REST OF LAMEA MARINE BIOTECHNOLOGY, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 103. REST OF LAMEA MARINE BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 104. REST OF LAMEA MARINE BIOTECHNOLOGY, BY END USE INDUSTRIES, 2022-2032 ($MILLION)
  • TABLE 105. AKER BIOMARINE AS: KEY EXECUTIVES
  • TABLE 106. AKER BIOMARINE AS: COMPANY SNAPSHOT
  • TABLE 107. AKER BIOMARINE AS: OPERATING SEGMENTS
  • TABLE 108. AKER BIOMARINE AS: PRODUCT PORTFOLIO
  • TABLE 109. AKER BIOMARINE AS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 110. BASF SE: KEY EXECUTIVES
  • TABLE 111. BASF SE: COMPANY SNAPSHOT
  • TABLE 112. BASF SE: OPERATING SEGMENTS
  • TABLE 113. BASF SE: PRODUCT PORTFOLIO
  • TABLE 114. BASF SE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 115. CP KELCO: KEY EXECUTIVES
  • TABLE 116. CP KELCO: COMPANY SNAPSHOT
  • TABLE 117. CP KELCO: OPERATING SEGMENTS
  • TABLE 118. CP KELCO: PRODUCT PORTFOLIO
  • TABLE 119. CP KELCO: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 120. CYANOTECH CORP.: KEY EXECUTIVES
  • TABLE 121. CYANOTECH CORP.: COMPANY SNAPSHOT
  • TABLE 122. CYANOTECH CORP.: OPERATING SEGMENTS
  • TABLE 123. CYANOTECH CORP.: PRODUCT PORTFOLIO
  • TABLE 124. CYANOTECH CORP.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 125. GLYCOMAR LTD.: KEY EXECUTIVES
  • TABLE 126. GLYCOMAR LTD.: COMPANY SNAPSHOT
  • TABLE 127. GLYCOMAR LTD.: OPERATING SEGMENTS
  • TABLE 128. GLYCOMAR LTD.: PRODUCT PORTFOLIO
  • TABLE 129. GLYCOMAR LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 130. LONZA GROUP LTD.: KEY EXECUTIVES
  • TABLE 131. LONZA GROUP LTD.: COMPANY SNAPSHOT
  • TABLE 132. LONZA GROUP LTD.: OPERATING SEGMENTS
  • TABLE 133. LONZA GROUP LTD.: PRODUCT PORTFOLIO
  • TABLE 134. LONZA GROUP LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 135. MARINOVA PTY LTD: KEY EXECUTIVES
  • TABLE 136. MARINOVA PTY LTD: COMPANY SNAPSHOT
  • TABLE 137. MARINOVA PTY LTD: OPERATING SEGMENTS
  • TABLE 138. MARINOVA PTY LTD: PRODUCT PORTFOLIO
  • TABLE 139. MARINOVA PTY LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 140. NEW ENGLAND BIOLABS INC: KEY EXECUTIVES
  • TABLE 141. NEW ENGLAND BIOLABS INC: COMPANY SNAPSHOT
  • TABLE 142. NEW ENGLAND BIOLABS INC: OPERATING SEGMENTS
  • TABLE 143. NEW ENGLAND BIOLABS INC: PRODUCT PORTFOLIO
  • TABLE 144. NEW ENGLAND BIOLABS INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 145. NOVAMATRIX: KEY EXECUTIVES
  • TABLE 146. NOVAMATRIX: COMPANY SNAPSHOT
  • TABLE 147. NOVAMATRIX: OPERATING SEGMENTS
  • TABLE 148. NOVAMATRIX: PRODUCT PORTFOLIO
  • TABLE 149. NOVAMATRIX: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 150. NUTREX HAWAII INC.: KEY EXECUTIVES
  • TABLE 151. NUTREX HAWAII INC.: COMPANY SNAPSHOT
  • TABLE 152. NUTREX HAWAII INC.: OPERATING SEGMENTS
  • TABLE 153. NUTREX HAWAII INC.: PRODUCT PORTFOLIO
  • TABLE 154. NUTREX HAWAII INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL MARINE BIOTECHNOLOGY MARKET SEGMENTATION
  • FIGURE 2. GLOBAL MARINE BIOTECHNOLOGY MARKET
  • FIGURE 3. SEGMENTATION MARINE BIOTECHNOLOGY MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN MARINE BIOTECHNOLOGY MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALMARINE BIOTECHNOLOGY MARKET
  • FIGURE 11. MARINE BIOTECHNOLOGY MARKET SEGMENTATION, BY BY PRODUCT TYPE
  • FIGURE 12. MARINE BIOTECHNOLOGY MARKET FOR MARINE ANIMAL TECHNOLOGY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. MARINE BIOTECHNOLOGY MARKET FOR MARINE PLANT TECHNOLOGY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. MARINE BIOTECHNOLOGY MARKET FOR MARINE BIOTECHNOLOGY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. MARINE BIOTECHNOLOGY MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 16. MARINE BIOTECHNOLOGY MARKET FOR COSMETICS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. MARINE BIOTECHNOLOGY MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. MARINE BIOTECHNOLOGY MARKET FOR FINE CHEMICAL, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. MARINE BIOTECHNOLOGY MARKET FOR NUTRITIONAL SUPPLEMENTS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. MARINE BIOTECHNOLOGY MARKET SEGMENTATION, BY BY END USE INDUSTRIES
  • FIGURE 21. MARINE BIOTECHNOLOGY MARKET FOR PHARMACEUTICAL, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 22. MARINE BIOTECHNOLOGY MARKET FOR BIOTECHNOLOGICAL, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 23. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 24. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 25. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 26. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 27. COMPETITIVE DASHBOARD
  • FIGURE 28. COMPETITIVE HEATMAP: MARINE BIOTECHNOLOGY MARKET
  • FIGURE 29. Top player positioning, 2022
  • FIGURE 30. AKER BIOMARINE AS: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 31. AKER BIOMARINE AS: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 32. AKER BIOMARINE AS: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 33. BASF SE: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 34. BASF SE: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 35. BASF SE: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 36. CP KELCO: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 37. CP KELCO: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 38. CP KELCO: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 39. CYANOTECH CORP.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 40. CYANOTECH CORP.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 41. CYANOTECH CORP.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 42. GLYCOMAR LTD.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 43. GLYCOMAR LTD.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 44. GLYCOMAR LTD.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 45. LONZA GROUP LTD.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 46. LONZA GROUP LTD.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 47. LONZA GROUP LTD.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 48. MARINOVA PTY LTD: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 49. MARINOVA PTY LTD: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 50. MARINOVA PTY LTD: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 51. NEW ENGLAND BIOLABS INC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 52. NEW ENGLAND BIOLABS INC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 53. NEW ENGLAND BIOLABS INC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 54. NOVAMATRIX: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 55. NOVAMATRIX: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 56. NOVAMATRIX: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 57. NUTREX HAWAII INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 58. NUTREX HAWAII INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 59. NUTREX HAWAII INC.: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now
RELATED TAGS

Purchase Full Report of
Marine Biotechnology Market

Start reading.
This Report and over 68,075+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers